Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Oct;72(4):1436-1444.e2.
doi: 10.1016/j.jvs.2019.12.043. Epub 2020 Feb 27.

Setting a research agenda for vascular Ehlers-Danlos syndrome using a patient and stakeholder engagement model

Liz Sage  1 , Melissa L Russo  2 , Peter H Byers  3 , John Demasi  4 , Shaine A Morris  5 , Lauren N Puryear  3 , Daphne S Fulton  6 , Sherene Shalhub  7 ; Vascular Ehlers-Danlos Syndrome Research Collaborative
Affiliations
Free article

Setting a research agenda for vascular Ehlers-Danlos syndrome using a patient and stakeholder engagement model

Liz Sage et al. J Vasc Surg. 2020 Oct.
Free article

Abstract

Objective: Vascular Ehlers-Danlos syndrome (vEDS) is a rare, syndromic, heritable condition with life-threatening complications that include aortic and arterial aneurysms, dissection, and rupture. This study describes the formation of the vEDS Research Collaborative and methods used for stakeholder engagement.

Methods: The vEDS Research Collaborative was established with an engagement award from the Patient-Centered Outcomes Research Institute to create a framework for a patient-researcher partnership. Between October 1, 2017, and September 30, 2018, the Collaborative used the Patient-Centered Outcomes Research Institute Engagement Rubric to conduct stakeholder engagement to develop a patient-centered research agenda. A modified Delphi technique was used to develop and to refine research topics and questions, gathering input from all stakeholders during three rounds of feedback.

Results: Four topic areas were deemed important: mental health and quality of life issues, creating a care team, a holistic approach to vEDS management (medical and surgical), and pregnancy management. An online survey to rank a list of 12 research questions in these topic areas in order of importance was disseminated. The questions were ranked in order of importance through an online survey (N = 197 responses). The survey showed a high degree of alignment in the top priorities among stakeholders. There was a high degree of interest in pragmatic clinical trials evaluating medical management options and health-related quality of life outcomes.

Conclusions: The vEDS Research Collaborative has built a sustainable, coalition model of patient and stakeholder engagement, supported by the vEDS community, to identify a patient-centered, prioritized list of research questions. In articulating a shared vision for the future of vEDS research, the Collaborative has laid the groundwork for developing research protocols aligned with the highest priority questions for the individuals affected by this serious condition that can be translated into future clinical trials.

Keywords: COL3A1 mutations; Patient and stakeholder engagement; Rare disease research; Research prioritization; Vascular Ehlers-Danlos syndrome.

PubMed Disclaimer

Publication types